71 related articles for article (PubMed ID: 9495805)
1. Topology inversion of CYP2D6 in the endoplasmic reticulum is not required for plasma membrane transport.
Loeper J; Le Berre A; Pompon D
Mol Pharmacol; 1998 Mar; 53(3):408-14. PubMed ID: 9495805
[TBL] [Abstract][Full Text] [Related]
2. Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent.
Loeper J; Louérat-Oriou B; Duport C; Pompon D
Mol Pharmacol; 1998 Jul; 54(1):8-13. PubMed ID: 9658184
[TBL] [Abstract][Full Text] [Related]
3. The catalytic activity of the endoplasmic reticulum-resident protein microsomal epoxide hydrolase towards carcinogens is retained on inversion of its membrane topology.
Friedberg T; Holler R; Löllmann B; Arand M; Oesch F
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):131-6. PubMed ID: 8870659
[TBL] [Abstract][Full Text] [Related]
4. Membrane topology and cell surface targeting of microsomal epoxide hydrolase. Evidence for multiple topological orientations.
Zhu Q; von Dippe P; Xing W; Levy D
J Biol Chem; 1999 Sep; 274(39):27898-904. PubMed ID: 10488137
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane.
Neve EP; Ingelman-Sundberg M
J Biol Chem; 2000 Jun; 275(22):17130-5. PubMed ID: 10747972
[TBL] [Abstract][Full Text] [Related]
6. An N-terminal glycosylation signal on cytochrome P450 is restricted to the endoplasmic reticulum in a luminal orientation.
Szczesna-Skorupa E; Kemper B
J Biol Chem; 1993 Jan; 268(3):1757-62. PubMed ID: 8420952
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes.
Yamamoto AM; Mura C; De Lemos-Chiarandini C; Krishnamoorthy R; Alvarez F
Clin Exp Immunol; 1993 Jun; 92(3):381-90. PubMed ID: 7685669
[TBL] [Abstract][Full Text] [Related]
8. Toward a systems approach to the human cytochrome P450 ensemble: interactions between CYP2D6 and CYP2E1 and their functional consequences.
Davydov DR; Davydova NY; Rodgers JT; Rushmore TH; Jones JP
Biochem J; 2017 Oct; 474(20):3523-3542. PubMed ID: 28904078
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and characterization of mouse CYP2d22.
Yu AM; Haining RL
Drug Metab Dispos; 2006 Jul; 34(7):1167-74. PubMed ID: 16595712
[TBL] [Abstract][Full Text] [Related]
10. Membrane topology of NADPH-cytochrome P450 reductase on the endoplasmic reticulum.
Kida Y; Ohgiya S; Mihara K; Sakaguchi M
Arch Biochem Biophys; 1998 Mar; 351(2):175-9. PubMed ID: 9515054
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of CYP2D6.31 variant: homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution.
Allorge D; Bréant D; Harlow J; Chowdry J; Lo-Guidice JM; Chevalier D; Cauffiez C; Lhermitte M; Blaney FE; Tucker GT; Broly F; Ellis SW
Proteins; 2005 May; 59(2):339-46. PubMed ID: 15726636
[TBL] [Abstract][Full Text] [Related]
12. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
Muratori L; Parola M; Ripalti A; Robino G; Muratori P; Bellomo G; Carini R; Lenzi M; Landini MP; Albano E; Bianchi FB
Gut; 2000 Apr; 46(4):553-61. PubMed ID: 10716687
[TBL] [Abstract][Full Text] [Related]
13. Evidence that biosynthesis of phosphatidylethanolamine, phosphatidylcholine, and triacylglycerol occurs on the cytoplasmic side of microsomal vesicles.
Coleman R; Bell RM
J Cell Biol; 1978 Jan; 76(1):245-53. PubMed ID: 618895
[TBL] [Abstract][Full Text] [Related]
14. Candida maltosa NADPH-cytochrome P450 reductase: cloning of a full-length cDNA, heterologous expression in Saccharomyces cerevisiae and function of the N-terminal region for membrane anchoring and proliferation of the endoplasmic reticulum.
Kärgel E; Menzel R; Honeck H; Vogel F; Böhmer A; Schunck WH
Yeast; 1996 Mar; 12(4):333-48. PubMed ID: 8701606
[TBL] [Abstract][Full Text] [Related]
15. Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6.
Hayhurst GP; Harlow J; Chowdry J; Gross E; Hilton E; Lennard MS; Tucker GT; Ellis SW
Biochem J; 2001 Apr; 355(Pt 2):373-9. PubMed ID: 11284724
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 activities toward model CYP2D6 substrates dextromethorphan, bufuralol, and debrisoquine.
Marcucci KA; Pearce RE; Crespi C; Steimel DT; Leeder JS; Gaedigk A
Drug Metab Dispos; 2002 May; 30(5):595-601. PubMed ID: 11950793
[TBL] [Abstract][Full Text] [Related]
17. Characterization of dextromethorphan O- and N-demethylation catalyzed by highly purified recombinant human CYP2D6.
Yu A; Dong H; Lang D; Haining RL
Drug Metab Dispos; 2001 Nov; 29(11):1362-5. PubMed ID: 11602510
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57).
Sakuyama K; Sasaki T; Ujiie S; Obata K; Mizugaki M; Ishikawa M; Hiratsuka M
Drug Metab Dispos; 2008 Dec; 36(12):2460-7. PubMed ID: 18784265
[TBL] [Abstract][Full Text] [Related]
19. Recombinant production of human microsomal cytochrome P450 2D6 in the methylotrophic yeast Pichia pastoris.
Dietrich M; Grundmann L; Kurr K; Valinotto L; Saussele T; Schmid RD; Lange S
Chembiochem; 2005 Nov; 6(11):2014-22. PubMed ID: 16222729
[TBL] [Abstract][Full Text] [Related]
20. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.
Robin MA; Maratrat M; Le Roy M; Le Breton FP; Bonierbale E; Dansette P; Ballet F; Mansuy D; Pessayre D
J Clin Invest; 1996 Sep; 98(6):1471-80. PubMed ID: 8823314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
